SCHEMBL26813698

SCHEMBL26813698

Cc1ccccc1-c1c2cc(C(C)C)ccc2nc[n+]1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.38
CLK4 Q9HAZ1 10/20 0.38
CYP3A4 P08684 8/20 0.38
CYP2C19 P33261 8/20 0.38
CYP1A2 P05177 7/20 0.38
TSHR P16473 7/20 0.38
ALDH1A1 P00352 7/20 0.38
CYP2D6 P10635 6/20 0.38
MAPK1 P28482 5/20 0.38
CYP2C9 P11712 3/20 0.38
MAPK14 Q16539 2/20 0.36
LCK P06239 2/20 0.36
KDR P35968 2/20 0.36
JAK3 P52333 1/20 0.36
HSD17B10 Q99714 3/20 0.36
TP53 P04637 2/20 0.36
ALOX15 P16050 2/20 0.36
CTSD P07339 1/20 0.35
BACE1 P56817 1/20 0.35
USP2 O75604 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26060419 0.91 LMNA (0.39) LMNACLK4CYP3A4CYP2C19CYP1A2
SCHEMBL26813692 0.83 CYP1A2 (0.38) LMNACLK4CYP3A4CYP2C19CYP1A2
SCHEMBL26813596 0.81 CYP3A4 (0.33) LMNACLK4CYP3A4CYP2C19CYP1A2
SCHEMBL25445494 0.80 PI4KA (0.39) CYP3A4CYP2C19CYP1A2ALDH1A1MAPK14
SCHEMBL25445415 0.80 ADORA2A (0.41) LMNACLK4CYP3A4CYP2C19CYP1A2
SCHEMBL26813690 0.76 HTR1A (0.38) LMNACLK4CYP3A4CYP2C19CYP1A2
SCHEMBL26794245 0.76 LMNA (0.40) LMNACYP1A2ALDH1A1HSD17B10CTSD
SCHEMBL26060534 0.74 LMNA (0.36) LMNACLK4MAPK14LCKKDR
SCHEMBL26060417 0.74 DHODH (0.32) MAPK14LCKKDRJAK3
SCHEMBL25442958 0.73 LMNA (0.40) LMNACRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11832456-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-11-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11832456-B2 Organic electroluminescent materials and devices CPNE4, CYBA, EPCAM LMNA 2800/4885CLK4 1282/4885CYP3A4 714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.